Clinical trials
Withdrawn Phase 3 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shandong University | 4 |
| Sun Yat-sen University | 4 |
| Children's Hospital of Fudan University | 3 |
| Fudan University | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Nanjing First Hospital, Nanjing Medical University | 2 |
| Shanghai Henlius Biotech | 2 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Bristol-Myers Squibb | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 4 |
| Purpura, Thrombocytopenic, Idiopathic | 4 |
| Breast Neoplasms | 3 |
| Esophageal Neoplasms | 2 |
| Nephrotic Syndrome | 2 |
| Purpura | 2 |
| Stomach Neoplasms | 2 |
| COVID-19 | 1 |
| Carcinoma, Transitional Cell | 1 |
| Coronary Artery Disease | 1 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.